With medical marijuana set for reclassification into Schedule III, Midwest businesses could see major impacts in doing ...

The reclassification of cannabis as a Schedule III substance is meant to remove barriers for researchers but its effects ...

The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say ...

CHICAGO - A major shift in federal marijuana policy could have a big impact on Illinois’ cannabis industry. The Trump ...

The federal government is reclassifying medical marijuana, categorizing it as a drug with potential medical benefits and less ...

When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for ...

Over the last three decades, 40 states have legalized the sale and use of medical marijuana in one form or another. Last week ...

The Trump administration is reclassifying state-licensed medical marijuana as a less dangerous drug. Local providers say the ...

On April 22, Bloomberg reported, citing an on-air discussion with CEO Irwin Simon, that Tilray Brands, Inc. (NASDAQ:TLRY) ...

Acting Attorney General Todd Blanche signed an order under President Trump’s direction on Thursday to reclassify ...